GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Daan Gene Co Ltd (SZSE:002030) » Definitions » EV-to-FCF

Daan Gene Co (SZSE:002030) EV-to-FCF : 38.35 (As of Jul. 16, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Daan Gene Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Daan Gene Co's Enterprise Value is ¥8,367.6 Mil. Daan Gene Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was ¥218.2 Mil. Therefore, Daan Gene Co's EV-to-FCF for today is 38.35.

The historical rank and industry rank for Daan Gene Co's EV-to-FCF or its related term are showing as below:

SZSE:002030' s EV-to-FCF Range Over the Past 10 Years
Min: -43335.44   Med: 10.02   Max: 3362.61
Current: 38.8

During the past 13 years, the highest EV-to-FCF of Daan Gene Co was 3362.61. The lowest was -43335.44. And the median was 10.02.

SZSE:002030's EV-to-FCF is ranked worse than
75.45% of 391 companies
in the Biotechnology industry
Industry Median: 8.53 vs SZSE:002030: 38.80

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-07-16), Daan Gene Co's stock price is ¥6.32. Daan Gene Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0.360. Therefore, Daan Gene Co's PE Ratio (TTM) for today is At Loss.


Daan Gene Co EV-to-FCF Historical Data

The historical data trend for Daan Gene Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daan Gene Co EV-to-FCF Chart

Daan Gene Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.49 9.93 7.28 63.38 59.30

Daan Gene Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.58 14.32 31.55 59.30 35.52

Competitive Comparison of Daan Gene Co's EV-to-FCF

For the Biotechnology subindustry, Daan Gene Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daan Gene Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Daan Gene Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Daan Gene Co's EV-to-FCF falls into.


;
;

Daan Gene Co EV-to-FCF Calculation

Daan Gene Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=8367.574/218.186
=38.35

Daan Gene Co's current Enterprise Value is ¥8,367.6 Mil.
Daan Gene Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥218.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daan Gene Co  (SZSE:002030) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Daan Gene Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=6.32/-0.360
=At Loss

Daan Gene Co's share price for today is ¥6.32.
Daan Gene Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.360.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Daan Gene Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Daan Gene Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Daan Gene Co Business Description

Traded in Other Exchanges
N/A
Address
No.19 Xiangshan Road, Science Park, High & New Technology Development District, Guangdong, Guangzhou, CHN, 510665
Daan Gene Co Ltd is a high-tech enterprise-oriented in molecular diagnostic techniques. It is primarily committed to research and development, production, and service of in-vitro diagnostic products, including qPCR, Sequeacing, TRF, ELISA, and Liquid-Based Cytology diagnostic kits and equipment. Geographically, tahe group operates in China.
Executives
Zhou Xin Yu Directors, executives
He Yun Shao Director
Huang Ru Hui Supervisors
Cheng Gang Directors, executives
Xu Qing Supervisors
He Li Xin Supervisors

Daan Gene Co Headlines

No Headlines